Is COVID-19 associated with latent toxoplasmosis?

被引：0
作者：
Salman Ghaffari
Narges Kalantari
Tahmineh Gorgani-Firouzjaee
Masomeh Bayani
Farzaneh Jalali
Meysam Aghajani Daroonkola
机构：
[1] Babol University of Medical Sciences,Department of Parasitology and Mycology, School of Medicine
[2] Health Research Institute,Cellular and Molecular Biology Research Centre
[3] Babol University of Medical Sciences,Infectious Diseases and Tropical Medicine Research Centre
[4] Babol University of Medical Sciences,Laboratory Sciences Group, Faculty of Para
[5] Babol University of Medical Sciences,Medicine
[6] Babol University of Medical Sciences,Shahid Yahyanejad Hospital
来源：
Environmental Science and Pollution Research | 2021年 / 28卷
关键词：
COVID-19; Seroprevalence; Toxoplasmosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The present study aimed to evaluate the possible association between coronavirus disease 2019 (COVID-19) and latent Toxoplasma gondii infection in a group of patients and healthy individuals. Blood samples were obtained from 269 PCR-positive COVID-19 patients. The serum was separated and tested for the existence of anti-T. gondii antibodies (IgG) using a commercial enzyme-linked immunosorbent assay kit. The prevalence of latent toxoplasmosis between a subgroup of the patients (aged under 55 years old) and COVID-19 negative individuals was compared. Anti-T. gondii antibodies were found in 226/269 (84.0%) patients with COVID-19. Anti-Toxoplasma antibodies were detected in 72/91 (79.1%) cases and 96/123 (78.0%) COVID-19 negative individuals (odd ratio = 1.1; 95% confidence interval: 0.55–2.07, P = 0.85). The median and interquartile range (IQR) of the IgG titer were not statistically significant different between case (97.3 [31.0–133.5]) and control groups (34.4 [13.0–144.5]) (P = 0.10). These findings demonstrated that latent Toxoplasma infection is prevalent amongst the COVID-19 patients. It also did not find any significant association between chronic toxoplasmosis and COVID-19.
引用
收藏
页码：67886 / 67890
页数：4
相关论文
共 58 条
  • [1] Abbas I(2020)A review on toxoplasmosis in humans and animals from Egypt Parasitol 147 135-159
  • [2] Villena I(2019)Sero-prevalence of BMC Infect Dis 19 1-8
  • [3] Dubey J(2021) and associated risk factors among psychiatric outpatients attending University of Gondar Hospital, Northwest Ethiopia Environ Sci Pollut Res 28 28825-28830
  • [4] Achaw B(2021)Causes of respiratory failure in COVID-19 patients Environ Sci Pollut Res 28 40445-40459
  • [5] Tesfa H(2021)Coronaviruses in humans and animals: the role of bats in viral evolution Environ Sci Pollut Res 28 19589-19600
  • [6] Zeleke AJ(2015)COVID-19: a new emerging respiratory disease from the neurological perspective Asian Pac J Trop Biomed 5 44-47
  • [7] Worku L(2018)Preliminary study on association between toxoplasmosis and breast cancer in Iran Trop Biomed 35 1017-1027
  • [8] Addisu A(2020)Seroprevalence and molecular detection of Microbiol Aust 41 45-50
  • [9] Yigzaw N(2020) in young healthy blood donors in Northern Iran Int J Environ Res Public Health 17 4809-516
  • [10] Tegegne Y(2021)COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t J Neuroimmune Pharmacol 16 513-undefined
123456